The Viennese bio-tech startup G. ST Antivirals was founded in 2019 and focuses on the development of products against respiratory viruses that cause colds and flu infections. In addition, G. ST Antivirals has recently entered into a cooperation with the Japanese pharmaceutical company Takeda to research common antiviral products against COVID-19.
IST cube is a lead investor
As has now become known, G. ST Antivirals was able to secure an investment in the mid six-figure range in a first round of financing. The participation takes place through a syndicate, which is directed by IST cube.
IST cube is an investment fund launched by the Institute of Science and Technology Austria together with other investors. He focuses on startups with an academic background, as well as young high-tech companies from Austria, which are provided with funding in early development phases as well as follow-up financing.
Start-up labs of the Vienna Business Agency
G. ST Antivirals is currently located in the laboratories of the MedUni Vienna, but will shortly transfer the activities to the start-up labs of the Vienna Business Agency. With the now secured investment, the startup wants to expand the product and application portfolio and finance further clinical research.
G. ST Antivirals’ approach
In its work, G. ST Antivirals pursues an innovative strategy, which consists in depriving the viral pathogen of the nutrient products of the host cell. After each virus relies exclusively on the building blocks made available by the host cell, the virus is starved within the cell.
Guido Gualdoni, co-founder and CEO of G. ST Antivirals, emphasizes: “The further development of innovative concepts for antiviral therapy now appears more important than ever. With our new investors, we have brought a broad national and international network and extensive know-how, especially in the field of university spin-offs, on board. Together with the expansion of our team and the move to our new laboratories in the recently opened start-up labs, this investment heralds a new phase in the development of G. ST. ”
=> to the startup’s page
–
